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Background Scanning with technetium-99m
methoxyisobutylisonitrile (99mTc-MIBI) is recommended for
evaluating thyroid nodule metabolism. In addition, it may
help differentiate between benign and malignant nodules;
however, the efficacy of this technique has not been fully
elucidated. Therefore, it is not currently performed for
routine clinical application. This prospective study was
conducted to investigate the clinical significance
of 99mTc-MIBI scintigraphy in the assessment of patients
with cold thyroid nodules.
Patients and methods This prospective study was
conducted on 104 patients with cold thyroid nodules
greater than 1 cm in diameter as detected on
99mTc-pertechnetate scintigraphy. Uptake of MIBI in thyroid
nodules was compared with that in the surrounding normal
thyroid tissue for both early and delayed images, and a score
of 0–3 was assigned to each nodule as follows: 0, cold; 1,
decreased; 2, equal; 3, increased. The thyroid scan was
performed 20 and 40min after intravenous injection of
555MBq of 99mTc-MIBI. The patients underwent fine-needle
aspiration cytology (FNAC). Detailed statistical parameters
were determined on a per-nodule basis for each qualitative
and quantitative scan analysis, as defined by histology.
Results A total of 104 patients (93 women and 11 men;
mean age 40.76±11.40 years, range 20–73) with a total
number of 167 cold nodules were included in this study.
When 99mTc-MIBI uptake was regarded as the criterion
of malignancy in 99mTc-MIBI scintigraphy, the accuracy
was between 69.46 and 92.21% on using seven different
methods. In addition, FNAC findings indicated a sensitivity
of 66.66%, a specificity of 100%, a negative predictive value
of 95.72%, a positive predictive value of 100%, and an
accuracy of 96.06%. Six malignant cold nodules were
detected on a positive 99mTc-MIBI scan, which were
determined as benign nodules on FNAC examinations.
Conclusion The study demonstrated that 99mTc-MIBI
scanning can be complementary to other diagnostic
techniques in patients with cold thyroid nodules. In
addition, because of its availability, rather low cost,
simple protocol, and objective semiquantitative
information, 99mTc-MIBI scanning seems to hold promise
in routine imaging of cold thyroid nodules. Nucl Med
Commun 35:51–57 c 2013 Wolters Kluwer Health |
Lippincott Williams & Wilkins.
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Introduction
Thyroid carcinoma is a curable cancer characterized by a
nonfunctioning (cold) nodule detected on a technetium
pertechnetate scan [1]. Thyroid nodules are quite
common, occurring in at least 4–7% of the population [2].
Early and accurate differentiation between malignant and
benign nodules can be challenging but is critical to the
patient’s outcome [1]. Studies have indicated a pre-
valence of 4–50% for malignancy in thyroid nodules,
depending on the surgical indication [3].
Clinical examination gives limited information on the
benign or malignant nature of the cold thyroid nodule
(CTN). Therefore, other methods such as fine-needle
aspiration cytology (FNAC) and ultrasonography are
recommended to obtain further diagnostic informa-
tion [4–6]. Although there are regional differences in
the method of choice for initial evaluation, it is generally
accepted that, along with laboratory thyroid function
tests, FNAC should be the first procedure to be
performed. Our previous study revealed that the sensi-
tivity, specificity, positive predictive value (PPV), nega-
tive predictive value (NPV), and diagnostic accuracy of
FNAC were 53.84, 98.01, 82.35, 92.50, and 81.81%,
respectively [7]. However, with a published sensitivity of
68–98% (mean 83%) and a specificity of 72–100% (mean
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92%), FNAC does not seem to be a perfect diagnostic
test for the evaluation of thyroid nodules [7,8].
In this respect, a number of scintigraphic modalities such as
131I, 123I, 99mTc, 201Tl, technetium-99m methoxyisobutyliso-
nitrile (99mTc-MIBI), and 18F-fluorodeoxyglucose have been
assessed for the scintigraphic recognition of malignant
nodules [4,5,9]. The majority of such studies have used
99mTc-MIBI to evaluate thyroid nodule metabolism. The
intensity and/or time course of uptake are used for
the differentiation of benign from malignant nodules. How-
ever, the published results are not consensual [10–13]. The
procedure offers high patient acceptability, low cost, easy
protocol, and good image quality. However, the efficacy of the
99mTc-MIBI scan in this issue is not fully elucidated. As such,
the aim of this prospective study was to investigate the
clinical significance of 99mTc-MIBI scintigraphy in the
assessment of patients with CTNs. The results of this
modality were compared with the histological diagnosis of
the thyroidectomy specimen as the reference (gold) standard
for the presence or absence of malignancy (thyroid cancer).
In addition, we had two other objectives: (a) whenever
possible, compare this modality with FNAC; and (b) assess
the feasibility of this radiotracer for routine practice.
Patients and methods
In total, 104 patients with at least one cold nodule on
previous 99mTc-pertechnetate scintigraphy were included
in the study conducted between May 2011 and April
2013. Patients with previous thyroid surgery, known
malignant disease, or nonpalpable thyroid nodules smaller
than 1 cm in diameter were excluded. In addition, pregnant
and nursing women, as well as children (under 14 years old),
were also excluded. Besides 99mTc-pertechnetate scinti-
graphy, all 104 patients had previously undergone an
ultrasound examination, FNAC, thyroid hormone mea-
surements (sensitive TSH, free thyroxine), and 99mTc-
MIBI thyroid scans, and all had previously been selected
for surgery on the basis of their clinical and paraclinical
findings.
The study complies with the declaration of Helsinki and
was approved by the institutional ethics committee of
Bushehr University of Medical Sciences; all patients gave
written informed consent.
Fine-needle aspiration cytology
FNAC was performed by experts using the suction
technique and a 23-G needle. Between three and four
samples were obtained from different nodule areas. The
samples were smeared on at least four glass slides, two for
air-drying and two for fixation in methanol. Dry smears
were stained by Wright–Giemsa and methanol-fixed
smears were stained by Papanicolaou. All samples were
assessed by expert thyroid gland pathologists, and the
results were reported by consensus according to
the classification of the American Association of Clinical
Endocrinologists Consensus for the study of thyroid
nodules [14] as follows: (a) nondiagnostic, (b) benign
(non-neoplastic), (c) follicular lesion/neoplasm, (d) suspi-
cious, (e) or positive for malignant cells.
99mTc-MIBI scans
Two MIBI thyroid scans were obtained for each patient.
Early MIBI thyroid scans were obtained 20min after
intravenous administration of 555MBq of 99mTc-MIBI.
A second (late) set of MIBI scans was obtained under the
same conditions, 40min after intravenous administration
of MIBI. All scans were obtained for the anterior
projection of the neck with a double-detector gamma
camera (ADAC Genesys, Malpitas, California, USA)
equipped with a general-purpose parallel-hole, low-
energy collimator. Images were obtained in a 128 128
matrix using a digital zoom of 2.
The acquisition time for both (early and late) images was
set at 5min with a 20% window centered at 140 keV in all
cases. For 99mTc-MIBI scintigraphy, as had been used in
prior studies [15], accumulation of the tracer in the
nodules was visually scored and semiquantitative analysis
was performed. Images were assessed by two nuclear
medicine physicians and discrepant results were resolved
by consensus.
99mTc-MIBI uptake in the nodules for both early and
delayed images was scored as follows: score 0 (cold), no
significant uptake; score 1 (decreased), uptake increased
as compared with background activity, but lower than that
in normal thyroid tissue; score 2 (equal), uptake equal to
that in normal thyroid tissue; and score 3 (increased),
uptake exceeding that in normal thyroid tissue. Semi-
quantitative analysis was performed using a lesion to
nonlesion ratio on early (ER) and delayed images (DR)
after background correction. A circular region of interest
was generated over the area of the thyroid nodule. For
background, circular regions of interest were drawn three
pixels below the normal lobe of the gland. In addition, a
retention index (RI) was calculated using the formula:
RI ¼ DRERð Þ100=ER:
Seven methods for the differential diagnosis of thyroid
nodules on 99mTc-MIBI scintigraphy were studied. In
method 1, a lesion scored 2 or 3 in the early image was
considered malignant; in method 2, a lesion scored 2 or 3 in
the delayed image was considered malignant; in method 3,
a lesion scored 3 in the early image was considered
malignant; in method 4, a lesion scored 3 in the delayed
image was considered malignant; in method 5, a lesion
scored 2 or 3 in the early or delayed images was considered
malignant; in method 6, a lesion scored 3 in the early or
delayed images was considered malignant; in method 7,
a lesion scored 3 on both early and delayed images was
considered malignant. These data were compared with the
results of histopathological studies.
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Statistical analysis
The distribution of variables was assessed using probability
plots and the Shapiro–Wilk test. Continuous variables
are expressed as mean±SD and categorical variables as
absolute values and percentages. A two-tailed t-test was
used to compare the mean values between the groups.
The sensitivity, specificity, accuracy, and positive and
NPVs of each imaging method were obtained on the basis
of the definitive diagnosis established through histo-
pathology. A receiver operating characteristic (ROC)
curve analysis was performed to determine ER, DR, and
RI threshold levels for the differentiation of malignant
from benign nodules. The results were considered
statistically significant when the P value was less than
0.05. Statistical analysis was performed using an IBM
computer (Armonk, New York, USA) and PASW software,
version 18.0 (SPSS Inc., Chicago, Illinois, USA).
Results
A total of 104 patients (93 women and 11 men; mean age
40.76±11.40 years, range 20–73) were included in this
study. The total number of cold nodules was 167: one
nodule in 72 patients, two nodules in 20 patients, three
nodules in five patients, and four nodules in 10 patients.
Seven patients were identified as having a suspicious/
follicular neoplasm on FNAC, which were revealed as
being benign on surgery and histopathology. Histological
findings were malignant in 14 patients (all cases of
papillary carcinoma) and benign in 90 patients (Table 1).
The mean size of malignant tissue was 5.5mm (range:
3–13mm).
Predictive value of 99mTc-MIBI for thyroid malignancy
compared with FNAC
When 99mTc-MIBI uptake was regarded as the criterion
for malignancy in 99mTc-MIBI scintigraphy, the accuracy
was between 69.46 and 92.21% on seven different
methods (Figs 1 and 2). On a comparison between these
seven methods, method 2 (scored 2 or 3 in the delayed
image) demonstrated the most reasonable detection rate
in the diagnosis of malignant cold nodules with a
sensitivity of 100%, specificity of 78.29%, NPV of 100%,
PPV of 31.25%, accuracy of 80.23%, positive likelihood
ratio of 0.45, and negative likelihood ratio of 0. The
detailed statistical parameters are noted in Table 2.
In addition, only 10 of 15 malignant cold nodules showed
increased uptake (score 3) in the early or delayed views;
the five remaining malignant cold nodules showed equal
activity (score 2) in the scans. In addition, patients with
suspicious or follicular neoplasm (class 3 or 4) based on
FNAC showed different patterns of uptake (Table 3).
Overall, FNAC findings indicated a sensitivity of 66.66%,
a specificity of 100%, an NPV of 95.72%, a PPV of 100%,
and an accuracy of 96.06%. Histopathology revealed six
malignant cold nodules, which were considered as benign
nodules on FNAC. All such nodules showed uptake on
99mTc-MIBI scintigraphy.
Semiquantitative analysis of malignant and benign
nodules
In semiquantitative analysis, 99mTc-MIBI uptake values
were higher in malignant nodules than in benign nodules
(P<0.05), either in the ER (mean value 1.23±0.69 vs.
0.61±0.50) or in the DR (mean value 1.49±0.70%
vs. 0.59±0.41). In addition, the RI value demonstrated
more activity in malignant nodules than in benign nodules
Table 1 Histopathology of cold thyroid nodules
Histopathology of nodules Frequency (%)
Nodular goiter 99 (59.3)
Colloid goiter 23 (13.8)
Adenomatous goiter 17 (10.2)
Follicular adenoma/neoplasia 4 (2.4)
Multinodular goiter with cystic changes 2 (1.2)
Adenomatous goiter with Hurtle cell changes 3 (1.8)
Nodular hyperplasia with hyperplasia and lymphocytic infiltration 4 (2.4)
Papillary cell carcinoma 15 (9.0)
Total 167 (100)
Fig. 1
(a) 99mTc-pertechnetate scintigraphy in a 42-year-old man with a cold nodule on the right lobe of the thyroid gland. (b, c) Significant 99mTc-MIBI
activity in the right side of the thyroid gland after 20min (b) and 40min (c). The lesion to nonlesion ratio on early views is 3.59 and that on delayed
images is 3.60. Two fine-needle aspiration cytology findings showed a nodular goiter but histopathology examination showed a papillary cancer
of 5mm diameter.
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(mean value; 0.29±0.16 vs. 0.00±0.22, P<0.05).
Furthermore, a significant difference was noted between
the ER and DR of the 99mTc-MIBI scan in malignant
nodules (mean value 1.23±0.69 vs. 1.49±0.70, P<0.05).
Similarly, such a difference was observed in benign
nodules (mean value 0.62±0.50 vs. 0.59±0.41, P<0.05).
To determine the predictive value of 99mTc-MIBI uptake
for the final outcome of each thyroid nodule, an ROC curve
analysis was performed separately for three values. The area
under the ROC curve was 0.882±0.03 (P<0.000) for the
ER, 0.911±0.03 (P<0.000) for the DR, and 0.826±0.052
(P<0.000) for the RI. Furthermore, considering the
optimal cutoff point for ER as 0.80, for DR as 0.11, and
for RI as 0.16, the sensitivity and specificity were calculated
as 93.3 and 73% for ER, 93.3 and 74% for DR, and 80 and
79% for RI, respectively (Fig. 3).
Discussion
Nodular disease of the thyroid gland is one of the most
frequent problems in endocrinology, and the optimum
diagnostic and therapeutic strategy for patients with
CTNs is still a matter of debate [15]. Currently, thyroid
FNAC is indicated as a critical test for the management
of thyroid nodules. However, standard FNAC is non-
diagnostic in 25–40% of cases, which include inadequate
specimens and indeterminate (suspicious) diagnoses [16].
Several imaging modalities such as ultrasound and
scintigraphy are also recommended for the evaluation of
thyroid nodules [17,18].
Thyroid ultrasonography is helpful as a guide for FNAC, to
confirm the presence of a mass and its relation to the thyroid,
and to assess the size or the number of thyroid nodules.
However, this technique is not capable of distinguishing
between benign and malignant nodules [18,19].
Published reports assessing thyroid nodules with various
radiotracers (e.g. 201Tl, 99mTc-MIBI, tetrofosmin,
Table 2 Comparison of statistical parameters in different methods of 99mTc-MIBI scintigraphy and fine-needle aspiration cytology
Method Sensitivity (%) Specificity (%) NPV (%) PPV (%) Accuracy (%) Positive likelihood ratio Negative likelihood ratio
1 100 67.10 100 23.07 70.05 0.3 0
2 100 78.29 100 31.25 80.23 0.45 0
3 66.66 94.07 96.62 52.63 91.61 1.11 0.03
4 66.66 93.42 96.59 50 85.62 1 0.03
5 100 66.44 100 22.72 69.46 0.29 0
6 66.66 92.76 96.57 47.61 90.41 0.90 0.03
7 66.66 94.73 96.64 55.55 92.21 1.25 0.03
FNAC 66.66 100 95.72 100 96.06 o 0.04
Method 1, a lesion scored 2 or 3 in the early image was considered malignant; method 2, a lesion scored 2 or 3 in the delayed image was considered malignant.; method
3, a lesion scored 3 in the early image was considered malignant; method 4, a lesion scored 3 in the delayed image was considered malignant; method 5, a lesion scored
2 or 3 in the early or delayed images was considered malignant; method 6, a lesion scored 3 in the early or delayed images was considered malignant; method 7, a lesion
scored 3 on both early and delayed images was considered malignant.
FNAC, fine-needle aspiration cytology.
Fig. 2
(a) 99mTc-pertechnetate scintigraphy in a 35-year-old woman with a cold nodule on the left lobe of the thyroid gland. (b, c) No 99mTc-MIBI activity in
the left side of the thyroid gland after 20min (b) and 40min (c). The lesion to nonlesion ratio on early views is 0.20 and that on delayed images is
0.24. FNAC and histopathology examination findings showed a nodular goiter.
Table 3 Tc-MIBI uptake in patients with suspicious/follicular
and malignant nodules based on fine-needle aspiration cytology
Suspicious/follicular Malignant
Uptake Early Delayed Early Delayed
0 (no uptake) 2 3 0 0
1 (decreased activity) 2 2 0 0
2 (equal activity) 3 2 5 5
3 (increased activity) 0 0 10 10
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18F-fluorodeoxyglucose) have not been able to clearly
differentiate between benign and malignant thyroid
nodules [11,20]. Ascertainment of the radiotracer uptake,
analysis of higher uptake relative to the surrounding
tissue, and assessment of dynamic changes in uptake
(difference between early and delayed scans) are all
attempted to differentiate between benign and malignant
thyroid nodules [21–23].
In this respect, 99mTc-MIBI scans of the thyroid have been
studied by several groups searching for differences between
benign and malignant CTNs. Both semiquantitative
methods (i.e. index calculation, washout rate calculation,
uptake differences between early and late images, etc.) and
visual methods have been used to assess the CTN [13,23].
However, the published information conveys the general
idea that MIBI scans are not sufficient for definitive
preoperative differentiation between the benign and
malignant nature of a CTN [11,23].
The present study was undertaken to evaluate the efficacy
of FNAC and 99mTc-MIBI scintigraphy to determine
thyroid cancer in patients with cold thyroid nodules. The
question posed was whether 99mTc-MIBI scintigraphy
could be applied in patients with cold nodules. This study
depicted its merit in routine management for identifying
thyroid cancer in such patients.
The results of this study suggest that a lack of uptake in a
cold thyroid nodule on 99mTc-MIBI scintigraphy is
indicative of a benign process, although the presence of
uptake in a cold nodule is not necessarily a sign
of malignancy. This finding is in line with a number of
studies that have documented a complete exclusion of
malignant processes in cold thyroid nodules without any
activity on 99mTc-MIBI scintigraphy.
In this study, different levels of activity were observed in
the early and late MIBI scans. When a nodule with equal
or increased uptake (score 2 or 3) in delayed views was
considered a malignant lesion, the scan provided 100%
sensitivity and an NPV of 100% in discriminating benign
from malignant cold nodules.
In this study, a negative MIBI scan indicated a benign
etiology in all patients. Therefore, when the MIBI scan is
negative, in the absence of other indications (e.g.
cosmetics, obstruction), invasive diagnostic procedures
and/or surgery should be avoided.
The PPV of the MIBI scan improved from 22.72% [when a
nodule with equal or increased uptake (score 2 or 3) in
early or delayed views was considered a malignant lesion] to
55.55% [when a nodule with increased uptake (score 3) in
early and delayed views was considered a malignant lesion].
Positive MIBI scans were indeed indeterminate or non-
diagnostic. Most patients with a positive MIBI scan had
benign cold nodules, as did all patients with a final
histological diagnosis of malignancy. Similarly, the prob-
ability of a nodule showing uptake on 99mTc-MIBI
scintigraphy divided by the probability of a nodule not
showing uptake (positive likelihood ratio) was 0.29–1.25 in
different methods.
Furthermore, score 2 was found in benign and malignant
CTNs; therefore, mere consideration of score 3 was not
suitable for differential diagnosis of malignant from
benign nodules. In addition, our results show that each
of the two tested diagnostic methods (FNAC and MIBI
scans) is independent and gives different complementary
diagnostic information. Similarly, this study shows that
the combined use of FNAC and MIBI scans provides the
best diagnostic accuracy in the study of CTNs. In other
words, the 99mTc-MIBI scan and FNAC are complemen-
tary rather than competitive methods.
In agreement with previous studies, differentiated
thyroid cancer (DTC) was never identified as a cold
nodule on MIBI scans [10,20,23,24]. Hurtado-Lopez
et al. [13] reviewed 13 published papers in which MIBI
was used for the evaluation of patients with CTNs. Of
the 448 patients, 127 (28.34%) had DTC, four (0.9%) had
medullary cancer, 314 (70.08%) had benign thyroid
disease, and three (0.66%) had anaplastic thyroid cancer
[13]. All 131 patients with DTC and medullary
cancer (127 and four patients, respectively) showed
MIBI uptake within the CTN. In the 314 patients with
Fig. 3
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Receiver operating characteristic curve analysis for the prediction
of malignant thyroid nodules based on 99mTc-MIBI uptake values.
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benign disease, MIBI scans were positive in 212 (67.5%)
and negative in 102 (32.5%). MIBI scans were positive in
only one of the three patients with anaplastic carcino-
ma [13]. The reviewed data show that the NPV of a
negative MIBI scan is 100%.
On semiquantitative analysis, this study demonstrates
that the delayed-view parameters are superior to those of
early scans for the differentiation of malignant from
benign thyroid nodules. Our findings were in agreement
with those of Erdil et al. [10] who found that malignant
thyroid nodules showed higher uptake of 99mTc-MIBI,
especially in delayed images. In addition, the ER, DR,
and RI values were higher in malignant nodules than in
cold nodules. However, the lesion to nonlesion ratio may
vary depending on the imaging techniques, the equip-
ment used, or the patient population. Therefore, each
laboratory is advised to establish its own threshold based
on a large series of patients.
The thyroid uptake of MIBI depends on the number of
mitochondria and the potential of plasma and mitochon-
drial membranes, because MIBI is held inside the
mitochondria [24]. Malignant cells in particular maintain
a more negative mitochondrial transmembrane potential
and, subsequently, encourage increased MIBI accumula-
tion because of their increased metabolic needs [24].
99mTc-MIBI is the most common myocardial perfusion
scanning agent in all nuclear medicine centers and is
available more readily than the aforementioned radio-
tracers; further, it can be routinely used in thyroid cold
nodule evaluation.
In summary, this study confirms that the post-test
likelihood for cancer in the setting of a negative MIBI
scan is 0% and a negative MIBI scan excludes DTC
cancer in all patients with CTN (NPV, 100%). We may
suggest a combination of fine-needle aspiration biopsy
and MIBI scan as a routine diagnostic approach to CTNs.
Although our study demonstrates good insight into the
application of 99m Tc-MIBI as compared with histopatho-
logy as the reference in the assessment of cold thyroid
nodules, it should be noted that it has some short-
comings. The major limitations are the exclusion of
patients with thyroid nodules smaller than 1 cm in
diameter because of the limited resolution of current
gamma cameras and the presence of papillary thyroid
cancer and absence of other types of thyroid cancers, both
of which may have influenced the results of this study;
therefore, such deficiencies should be considered in
further studies. In addition, we did not use pinhole
collimators or a SPECT/CTcamera, which may be useful,
especially for small nodules.
Conclusion
In this study, on the basis of the amount of activity in the
early and late MIBI scans, seven methods were assessed.
When a nodule with equal or increased uptake (score 2 or
3) in delayed views was considered a malignant lesion
(method 2), the scan provided 100% sensitivity and an
NPV of 100% in the discrimination of benign from
malignant cold nodules. Therefore, it can be comple-
mentary to other diagnostic techniques in patients with
cold thyroid nodules. In addition, because of its
availability, relative low cost, easy performance, and
objective semiquantitative data, 99mTc-MIBI scanning
might be established in routine imaging centers to assess
cold thyroid nodules; however, further study is needed to
validate its clinical role.
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